China regulator mulls cutting traditional medicine prices: report
Published on Dec 5, 2013 7:36 PM
HONG KONG (REUTERS) - Chinese regulators are considering cutting retail price limits on some traditional Chinese medicines (TCM) by as much as 10 per cent early next year, a newspaper controlled by the official Xinhua news agency reported.
This follows a regulatory crackdown on real or perceived corporate wrongdoing this year, with domestic and international manufacturers of infant formula and drugs coming under the spotlight.
The Economic Information Daily, citing unidentified sources, reported on Thursday that the National Development and Reform Commission (NDRC) was looking to reduce prices of top-end, non-essential products, which had risen sharply due to supportive policies.
Beijing Tongrentang and Shijiazhuang Yiling Pharmaceutical are among the firms that will be most affected, given the range of such medicines that they offer, the report said.
To continue reading, log in if you are a subscriber
If you are not a subscriber, you can get instant, unlimited access here